Charles Schwab Investment Management Inc. Purchases 970 Shares of National Research Co. (NASDAQ:NRC)

Charles Schwab Investment Management Inc. boosted its stake in National Research Co. (NASDAQ:NRC) by 0.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 124,711 shares of the company’s stock after acquiring an additional 970 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in National Research were worth $2,200,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of NRC. Norden Group LLC bought a new position in shares of National Research in the 4th quarter valued at about $182,000. Proficio Capital Partners LLC bought a new stake in shares of National Research during the 4th quarter valued at approximately $283,000. Bank of New York Mellon Corp increased its holdings in shares of National Research by 88.5% during the fourth quarter. Bank of New York Mellon Corp now owns 217,212 shares of the company’s stock worth $3,832,000 after buying an additional 101,957 shares in the last quarter. Principal Financial Group Inc. raised its position in National Research by 10.7% in the fourth quarter. Principal Financial Group Inc. now owns 12,018 shares of the company’s stock valued at $212,000 after purchasing an additional 1,161 shares during the last quarter. Finally, Exchange Traded Concepts LLC raised its stake in shares of National Research by 17.2% during the fourth quarter. Exchange Traded Concepts LLC now owns 16,421 shares of the company’s stock valued at $290,000 after acquiring an additional 2,412 shares during the last quarter. 47.26% of the stock is currently owned by institutional investors.

National Research Price Performance

National Research stock opened at $12.91 on Friday. The firm has a market cap of $296.23 million, a P/E ratio of 12.30 and a beta of 0.47. National Research Co. has a one year low of $12.88 and a one year high of $39.98. The company has a debt-to-equity ratio of 1.30, a current ratio of 0.47 and a quick ratio of 0.47. The stock’s 50 day moving average is $15.90 and its 200 day moving average is $18.06.

National Research (NASDAQ:NRC) last announced its quarterly earnings data on Monday, January 27th. The company reported $0.28 earnings per share (EPS) for the quarter. National Research had a return on equity of 66.52% and a net margin of 17.32%.

National Research Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 28th will be given a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 3.72%. The ex-dividend date is Friday, March 28th. National Research’s payout ratio is 45.71%.

National Research Company Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.